novel
strain
coronaviru
name
identifi
wuhan
citi
china
decemb
specif
therapi
avail
investig
regard
treatment
still
lack
prompt
us
perform
preliminari
silico
studi
proteas
antimalari
compound
search
potenti
inhibitor
calcul
log
p
log
valu
addit
molecular
dock
pass
predict
among
seven
studi
compound
mepacrin
appear
potenti
inhibitor
follow
chloroquin
hydroxychloroquin
phomarin
therefor
antimalari
drug
may
potenti
drug
candid
treatment
novel
coronaviru
detail
analysi
inhibitor
current
progress
clinic
studi
invit
investig
potenti
medicin
use
begin
year
coronaviru
diseas
recogn
wuhan
china
subsequ
start
spread
across
globe
put
whole
world
high
alert
led
total
case
death
world
includ
china
countri
till
januari
india
first
case
coronavirus
infect
human
vertebr
anim
affect
respiratori
digest
liver
central
nervou
system
sinc
incept
end
continu
effort
made
research
develop
diagnost
therapeut
vaccin
novel
coronaviru
base
result
clinic
trial
report
chloroquin
phosphat
antimalari
drug
certain
cur
effect
particular
chloroquin
phosphat
recommend
treat
associ
pneumonia
larger
popul
futur
subsequ
anoth
research
base
clinic
trial
suggest
hydroxychloroquin
ad
azithromycin
effect
treatment
motiv
us
perform
systemat
studi
antimalari
drug
use
molecular
dock
reinvestig
biolog
activ
pharmacolog
effect
studi
becom
import
offer
insight
structurebas
drug
design
recent
lin
et
al
report
structurebas
stabil
nonn
proteinprotein
interact
coronaviru
antivir
drug
design
howev
exist
systemat
studi
inhibit
coronaviru
antimalari
drug
best
knowledg
therefor
believ
studi
offer
better
insight
bind
interact
antimalari
drug
receptor
identifi
potenti
bind
site
antimalari
compound
perform
autom
silico
moleculardock
procedur
use
swissdock
web
server
base
dock
algorithm
eadock
ess
use
main
proteas
corona
virus
potenti
target
protein
obtain
rcsb
protein
data
bank
pdb
id
process
coordin
file
ligand
protein
upload
dock
perform
use
accur
paramet
option
exhaust
term
bind
mode
sampl
also
calcul
lipophil
log
p
aqueou
solubl
log
alogp
program
program
base
electrotopolog
state
indic
associ
neural
network
model
develop
tetko
et
al
log
p
log
two
import
paramet
quantit
structureproperti
relationship
qspr
studi
order
explor
predict
pharmacolog
effect
biolog
activ
molecul
use
pass
softwar
pass
predict
pharmacolog
effect
molecular
mechan
action
mutagen
carcinogen
teratogen
embryotox
chosen
seven
popular
antimalari
compound
ligand
proteas
name
mepacrin
chloroquin
quinin
hydroxychloroquin
artemisinin
phomarin
proguanil
molecular
structur
drug
display
fig
order
assess
compar
biolog
activ
comput
log
p
log
valu
list
tabl
log
p
close
associ
transport
properti
drug
interact
receptor
wherea
log
import
factor
affect
bioavail
one
see
log
p
valu
compound
lie
rang
chloroquin
log
p
valu
follow
hydroxychloroquin
log
p
howev
mepacrin
highest
log
p
among
seven
compound
studi
work
likewis
log
valu
antimalari
compound
rang
gener
drug
log
valu
rang
valu
virtual
none
valu
log
lie
except
mepacrin
log
slightli
log
p
log
valu
suggest
drug
molecul
may
easili
diffus
across
cell
membran
organ
lipid
solubl
quit
larg
studi
focus
main
proteas
novel
corona
viru
potenti
target
protein
treatment
main
proteas
found
deposit
pdb
file
earli
februari
therefor
chosen
potenti
target
molecular
dock
studi
molecular
dock
calcul
perform
blind
ie
cover
entir
protein
surfac
specif
region
protein
bind
pocket
order
avoid
sampl
bia
output
cluster
obtain
dock
step
rank
accord
full
fit
ff
score
swissdock
algorithm
greater
neg
ff
score
suggest
favor
bind
mode
ligand
receptor
better
fit
result
molecular
dock
display
fig
dock
paramet
bind
energi
ff
score
along
amino
acid
residu
found
activ
site
pocket
also
list
tabl
purpos
drug
design
desir
analyz
detail
biolog
activ
possibl
pharmacolog
effect
along
toxic
possibl
advers
effect
drug
compound
therefor
predict
activ
spectra
anti
malari
compound
use
pass
softwar
predict
base
studi
structur
activ
relationship
sar
train
set
includ
drug
drugcandid
lead
compound
whose
biolog
activ
report
experiment
averag
accuraci
predict
leaveoneout
crossvalid
supplementari
tabl
list
pharmacolog
effect
well
advers
affect
compound
pa
ensur
molecul
like
exhibit
activ
experi
furthermor
probabl
molecul
sever
close
analog
drug
quit
high
result
pass
predict
might
use
clinic
trial
drug
develop
stage
perform
systemat
studi
antimalari
compound
search
potenti
inhibitor
novel
coronaviru
proteas
base
bind
affin
mepacrin
appear
power
inhibitor
among
seven
compound
studi
howev
log
p
quit
high
log
valu
low
potenti
inhibitor
proteas
includ
chloroquin
hydroxychloroquin
phomarin
therefor
detail
analysi
drug
requir
meanwhil
suggest
clinic
trial
compound
suitabl
combin
pass
predict
may
use
clinic
trial
inhibitor
studi
direct
progress
lab
shall
report
shortli
